APPLICATION SITE MOVEMENT IMPAIRMENT

APPLICATION SITE MOVEMENT IMPAIRMENT was reported 6 times

APPLICATION SITE MOVEMENT IMPAIRMENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytolytic Agent [EPC] 1 0.0004
1 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
2 RANK Ligand Inhibitor [EPC] 1 0.0000
3 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
4 Platelet Aggregation Inhibitor [EPC] 1 0.0000
5 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000